Global Uric Acid-lowering Drugs Market Growth 2026-2032
The global Uric Acid-lowering Drugs market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032.
Uric acid-lowering drugs are medications used to manage conditions like gout,where elevated levels of uric acid in the blood lead to painful joint inflammation.These drugs work by either inhibiting the production of uric acid or enhancing its excretion from the body.Commonly prescribed medications include xanthine oxidase inhibitors such as allopurinol and febuxostat,which decrease uric acid production by blocking enzymes involved in its synthesis.Another class,uricosuric agents like probenecid,increase uric acid excretion by inhibiting its reabsorption in the kidneys.
United States market for Uric Acid-lowering Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Uric Acid-lowering Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Uric Acid-lowering Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Uric Acid-lowering Drugs players cover Teva, Mylan Pharmaceuticals, Takeda Pharmaceuticals, Sanwa Kagaku Kenkyusho, Towa Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Uric Acid-lowering Drugs Industry Forecast” looks at past sales and reviews total world Uric Acid-lowering Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Uric Acid-lowering Drugs sales for 2026 through 2032. With Uric Acid-lowering Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Uric Acid-lowering Drugs industry.
This Insight Report provides a comprehensive analysis of the global Uric Acid-lowering Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Uric Acid-lowering Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Uric Acid-lowering Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Uric Acid-lowering Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Uric Acid-lowering Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Uric Acid-lowering Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Uric Acid-lowering Drugs market?
What factors are driving Uric Acid-lowering Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Uric Acid-lowering Drugs market opportunities vary by end market size?
How does Uric Acid-lowering Drugs break out by Type, by Application?
Uric acid-lowering drugs are medications used to manage conditions like gout,where elevated levels of uric acid in the blood lead to painful joint inflammation.These drugs work by either inhibiting the production of uric acid or enhancing its excretion from the body.Commonly prescribed medications include xanthine oxidase inhibitors such as allopurinol and febuxostat,which decrease uric acid production by blocking enzymes involved in its synthesis.Another class,uricosuric agents like probenecid,increase uric acid excretion by inhibiting its reabsorption in the kidneys.
United States market for Uric Acid-lowering Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
China market for Uric Acid-lowering Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Europe market for Uric Acid-lowering Drugs is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 through 2032.
Global key Uric Acid-lowering Drugs players cover Teva, Mylan Pharmaceuticals, Takeda Pharmaceuticals, Sanwa Kagaku Kenkyusho, Towa Pharmaceutical, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2025.
LP Information, Inc. (LPI) ' newest research report, the “Uric Acid-lowering Drugs Industry Forecast” looks at past sales and reviews total world Uric Acid-lowering Drugs sales in 2025, providing a comprehensive analysis by region and market sector of projected Uric Acid-lowering Drugs sales for 2026 through 2032. With Uric Acid-lowering Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Uric Acid-lowering Drugs industry.
This Insight Report provides a comprehensive analysis of the global Uric Acid-lowering Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Uric Acid-lowering Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Uric Acid-lowering Drugs market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Uric Acid-lowering Drugs and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Uric Acid-lowering Drugs.
This report presents a comprehensive overview, market shares, and growth opportunities of Uric Acid-lowering Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- Uric Acid Production Inhibitors
- Urate-stimulating Excretion Agents
- Uric Acid Dissolving Agents
- Hyperuricemia
- Uric Acid Kidney Stones
- Gout
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Teva
- Mylan Pharmaceuticals
- Takeda Pharmaceuticals
- Sanwa Kagaku Kenkyusho
- Towa Pharmaceutical
- Toa Eiyo
- AstraZeneca
- Mochida Pharmaceutical
- Lannett Company
- Horizo??n Therapeutics
- Sanofi
- GSK
- Fuji Yakuhin
What is the 10-year outlook for the global Uric Acid-lowering Drugs market?
What factors are driving Uric Acid-lowering Drugs market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Uric Acid-lowering Drugs market opportunities vary by end market size?
How does Uric Acid-lowering Drugs break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Uric Acid-lowering Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Uric Acid-lowering Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Uric Acid-lowering Drugs by Country/Region, 2021, 2025 & 2032
2.2 Uric Acid-lowering Drugs Segment by Type
2.2.1 Uric Acid Production Inhibitors
2.2.2 Urate-stimulating Excretion Agents
2.2.3 Uric Acid Dissolving Agents
2.2.4 Uric Acid-lowering Drugs Sales by Type
2.2.4.1 Global Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Uric Acid-lowering Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Uric Acid-lowering Drugs Sale Price by Type (2021-2026)
2.3 Uric Acid-lowering Drugs Segment by Application
2.3.1 Hyperuricemia
2.3.2 Uric Acid Kidney Stones
2.3.3 Gout
2.3.4 Other
2.3.5 Uric Acid-lowering Drugs Sales by Application
2.3.5.1 Global Uric Acid-lowering Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Uric Acid-lowering Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Uric Acid-lowering Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Uric Acid-lowering Drugs Breakdown Data by Company
3.1.1 Global Uric Acid-lowering Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Uric Acid-lowering Drugs Sales Market Share by Company (2021-2026)
3.2 Global Uric Acid-lowering Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Uric Acid-lowering Drugs Revenue by Company (2021-2026)
3.2.2 Global Uric Acid-lowering Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Uric Acid-lowering Drugs Sale Price by Company
3.4 Key Manufacturers Uric Acid-lowering Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Uric Acid-lowering Drugs Product Location Distribution
3.4.2 Players Uric Acid-lowering Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR URIC ACID-LOWERING DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Uric Acid-lowering Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Uric Acid-lowering Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Uric Acid-lowering Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Uric Acid-lowering Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Uric Acid-lowering Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Uric Acid-lowering Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Uric Acid-lowering Drugs Sales Growth
4.4 APAC Uric Acid-lowering Drugs Sales Growth
4.5 Europe Uric Acid-lowering Drugs Sales Growth
4.6 Middle East & Africa Uric Acid-lowering Drugs Sales Growth
5 AMERICAS
5.1 Americas Uric Acid-lowering Drugs Sales by Country
5.1.1 Americas Uric Acid-lowering Drugs Sales by Country (2021-2026)
5.1.2 Americas Uric Acid-lowering Drugs Revenue by Country (2021-2026)
5.2 Americas Uric Acid-lowering Drugs Sales by Type (2021-2026)
5.3 Americas Uric Acid-lowering Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Uric Acid-lowering Drugs Sales by Region
6.1.1 APAC Uric Acid-lowering Drugs Sales by Region (2021-2026)
6.1.2 APAC Uric Acid-lowering Drugs Revenue by Region (2021-2026)
6.2 APAC Uric Acid-lowering Drugs Sales by Type (2021-2026)
6.3 APAC Uric Acid-lowering Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Uric Acid-lowering Drugs by Country
7.1.1 Europe Uric Acid-lowering Drugs Sales by Country (2021-2026)
7.1.2 Europe Uric Acid-lowering Drugs Revenue by Country (2021-2026)
7.2 Europe Uric Acid-lowering Drugs Sales by Type (2021-2026)
7.3 Europe Uric Acid-lowering Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Uric Acid-lowering Drugs by Country
8.1.1 Middle East & Africa Uric Acid-lowering Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Uric Acid-lowering Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Uric Acid-lowering Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Uric Acid-lowering Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Uric Acid-lowering Drugs
10.3 Manufacturing Process Analysis of Uric Acid-lowering Drugs
10.4 Industry Chain Structure of Uric Acid-lowering Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Uric Acid-lowering Drugs Distributors
11.3 Uric Acid-lowering Drugs Customer
12 WORLD FORECAST REVIEW FOR URIC ACID-LOWERING DRUGS BY GEOGRAPHIC REGION
12.1 Global Uric Acid-lowering Drugs Market Size Forecast by Region
12.1.1 Global Uric Acid-lowering Drugs Forecast by Region (2027-2032)
12.1.2 Global Uric Acid-lowering Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Uric Acid-lowering Drugs Forecast by Type (2027-2032)
12.7 Global Uric Acid-lowering Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Uric Acid-lowering Drugs Product Portfolios and Specifications
13.1.3 Teva Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Mylan Pharmaceuticals
13.2.1 Mylan Pharmaceuticals Company Information
13.2.2 Mylan Pharmaceuticals Uric Acid-lowering Drugs Product Portfolios and Specifications
13.2.3 Mylan Pharmaceuticals Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Mylan Pharmaceuticals Main Business Overview
13.2.5 Mylan Pharmaceuticals Latest Developments
13.3 Takeda Pharmaceuticals
13.3.1 Takeda Pharmaceuticals Company Information
13.3.2 Takeda Pharmaceuticals Uric Acid-lowering Drugs Product Portfolios and Specifications
13.3.3 Takeda Pharmaceuticals Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Takeda Pharmaceuticals Main Business Overview
13.3.5 Takeda Pharmaceuticals Latest Developments
13.4 Sanwa Kagaku Kenkyusho
13.4.1 Sanwa Kagaku Kenkyusho Company Information
13.4.2 Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Product Portfolios and Specifications
13.4.3 Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sanwa Kagaku Kenkyusho Main Business Overview
13.4.5 Sanwa Kagaku Kenkyusho Latest Developments
13.5 Towa Pharmaceutical
13.5.1 Towa Pharmaceutical Company Information
13.5.2 Towa Pharmaceutical Uric Acid-lowering Drugs Product Portfolios and Specifications
13.5.3 Towa Pharmaceutical Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Towa Pharmaceutical Main Business Overview
13.5.5 Towa Pharmaceutical Latest Developments
13.6 Toa Eiyo
13.6.1 Toa Eiyo Company Information
13.6.2 Toa Eiyo Uric Acid-lowering Drugs Product Portfolios and Specifications
13.6.3 Toa Eiyo Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Toa Eiyo Main Business Overview
13.6.5 Toa Eiyo Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Uric Acid-lowering Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Mochida Pharmaceutical
13.8.1 Mochida Pharmaceutical Company Information
13.8.2 Mochida Pharmaceutical Uric Acid-lowering Drugs Product Portfolios and Specifications
13.8.3 Mochida Pharmaceutical Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Mochida Pharmaceutical Main Business Overview
13.8.5 Mochida Pharmaceutical Latest Developments
13.9 Lannett Company
13.9.1 Lannett Company Company Information
13.9.2 Lannett Company Uric Acid-lowering Drugs Product Portfolios and Specifications
13.9.3 Lannett Company Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lannett Company Main Business Overview
13.9.5 Lannett Company Latest Developments
13.10 Horizo??n Therapeutics
13.10.1 Horizo??n Therapeutics Company Information
13.10.2 Horizo??n Therapeutics Uric Acid-lowering Drugs Product Portfolios and Specifications
13.10.3 Horizo??n Therapeutics Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Horizo??n Therapeutics Main Business Overview
13.10.5 Horizo??n Therapeutics Latest Developments
13.11 Sanofi
13.11.1 Sanofi Company Information
13.11.2 Sanofi Uric Acid-lowering Drugs Product Portfolios and Specifications
13.11.3 Sanofi Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sanofi Main Business Overview
13.11.5 Sanofi Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Uric Acid-lowering Drugs Product Portfolios and Specifications
13.12.3 GSK Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 Fuji Yakuhin
13.13.1 Fuji Yakuhin Company Information
13.13.2 Fuji Yakuhin Uric Acid-lowering Drugs Product Portfolios and Specifications
13.13.3 Fuji Yakuhin Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Fuji Yakuhin Main Business Overview
13.13.5 Fuji Yakuhin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Uric Acid-lowering Drugs Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Uric Acid-lowering Drugs by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Uric Acid-lowering Drugs by Country/Region, 2021, 2025 & 2032
2.2 Uric Acid-lowering Drugs Segment by Type
2.2.1 Uric Acid Production Inhibitors
2.2.2 Urate-stimulating Excretion Agents
2.2.3 Uric Acid Dissolving Agents
2.2.4 Uric Acid-lowering Drugs Sales by Type
2.2.4.1 Global Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
2.2.4.2 Global Uric Acid-lowering Drugs Revenue and Market Share by Type (2021-2026)
2.2.4.3 Global Uric Acid-lowering Drugs Sale Price by Type (2021-2026)
2.3 Uric Acid-lowering Drugs Segment by Application
2.3.1 Hyperuricemia
2.3.2 Uric Acid Kidney Stones
2.3.3 Gout
2.3.4 Other
2.3.5 Uric Acid-lowering Drugs Sales by Application
2.3.5.1 Global Uric Acid-lowering Drugs Sale Market Share by Application (2021-2026)
2.3.5.2 Global Uric Acid-lowering Drugs Revenue and Market Share by Application (2021-2026)
2.3.5.3 Global Uric Acid-lowering Drugs Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Uric Acid-lowering Drugs Breakdown Data by Company
3.1.1 Global Uric Acid-lowering Drugs Annual Sales by Company (2021-2026)
3.1.2 Global Uric Acid-lowering Drugs Sales Market Share by Company (2021-2026)
3.2 Global Uric Acid-lowering Drugs Annual Revenue by Company (2021-2026)
3.2.1 Global Uric Acid-lowering Drugs Revenue by Company (2021-2026)
3.2.2 Global Uric Acid-lowering Drugs Revenue Market Share by Company (2021-2026)
3.3 Global Uric Acid-lowering Drugs Sale Price by Company
3.4 Key Manufacturers Uric Acid-lowering Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Uric Acid-lowering Drugs Product Location Distribution
3.4.2 Players Uric Acid-lowering Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR URIC ACID-LOWERING DRUGS BY GEOGRAPHIC REGION
4.1 World Historic Uric Acid-lowering Drugs Market Size by Geographic Region (2021-2026)
4.1.1 Global Uric Acid-lowering Drugs Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Uric Acid-lowering Drugs Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Uric Acid-lowering Drugs Market Size by Country/Region (2021-2026)
4.2.1 Global Uric Acid-lowering Drugs Annual Sales by Country/Region (2021-2026)
4.2.2 Global Uric Acid-lowering Drugs Annual Revenue by Country/Region (2021-2026)
4.3 Americas Uric Acid-lowering Drugs Sales Growth
4.4 APAC Uric Acid-lowering Drugs Sales Growth
4.5 Europe Uric Acid-lowering Drugs Sales Growth
4.6 Middle East & Africa Uric Acid-lowering Drugs Sales Growth
5 AMERICAS
5.1 Americas Uric Acid-lowering Drugs Sales by Country
5.1.1 Americas Uric Acid-lowering Drugs Sales by Country (2021-2026)
5.1.2 Americas Uric Acid-lowering Drugs Revenue by Country (2021-2026)
5.2 Americas Uric Acid-lowering Drugs Sales by Type (2021-2026)
5.3 Americas Uric Acid-lowering Drugs Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Uric Acid-lowering Drugs Sales by Region
6.1.1 APAC Uric Acid-lowering Drugs Sales by Region (2021-2026)
6.1.2 APAC Uric Acid-lowering Drugs Revenue by Region (2021-2026)
6.2 APAC Uric Acid-lowering Drugs Sales by Type (2021-2026)
6.3 APAC Uric Acid-lowering Drugs Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Uric Acid-lowering Drugs by Country
7.1.1 Europe Uric Acid-lowering Drugs Sales by Country (2021-2026)
7.1.2 Europe Uric Acid-lowering Drugs Revenue by Country (2021-2026)
7.2 Europe Uric Acid-lowering Drugs Sales by Type (2021-2026)
7.3 Europe Uric Acid-lowering Drugs Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Uric Acid-lowering Drugs by Country
8.1.1 Middle East & Africa Uric Acid-lowering Drugs Sales by Country (2021-2026)
8.1.2 Middle East & Africa Uric Acid-lowering Drugs Revenue by Country (2021-2026)
8.2 Middle East & Africa Uric Acid-lowering Drugs Sales by Type (2021-2026)
8.3 Middle East & Africa Uric Acid-lowering Drugs Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Uric Acid-lowering Drugs
10.3 Manufacturing Process Analysis of Uric Acid-lowering Drugs
10.4 Industry Chain Structure of Uric Acid-lowering Drugs
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Uric Acid-lowering Drugs Distributors
11.3 Uric Acid-lowering Drugs Customer
12 WORLD FORECAST REVIEW FOR URIC ACID-LOWERING DRUGS BY GEOGRAPHIC REGION
12.1 Global Uric Acid-lowering Drugs Market Size Forecast by Region
12.1.1 Global Uric Acid-lowering Drugs Forecast by Region (2027-2032)
12.1.2 Global Uric Acid-lowering Drugs Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Uric Acid-lowering Drugs Forecast by Type (2027-2032)
12.7 Global Uric Acid-lowering Drugs Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Teva
13.1.1 Teva Company Information
13.1.2 Teva Uric Acid-lowering Drugs Product Portfolios and Specifications
13.1.3 Teva Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Teva Main Business Overview
13.1.5 Teva Latest Developments
13.2 Mylan Pharmaceuticals
13.2.1 Mylan Pharmaceuticals Company Information
13.2.2 Mylan Pharmaceuticals Uric Acid-lowering Drugs Product Portfolios and Specifications
13.2.3 Mylan Pharmaceuticals Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Mylan Pharmaceuticals Main Business Overview
13.2.5 Mylan Pharmaceuticals Latest Developments
13.3 Takeda Pharmaceuticals
13.3.1 Takeda Pharmaceuticals Company Information
13.3.2 Takeda Pharmaceuticals Uric Acid-lowering Drugs Product Portfolios and Specifications
13.3.3 Takeda Pharmaceuticals Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 Takeda Pharmaceuticals Main Business Overview
13.3.5 Takeda Pharmaceuticals Latest Developments
13.4 Sanwa Kagaku Kenkyusho
13.4.1 Sanwa Kagaku Kenkyusho Company Information
13.4.2 Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Product Portfolios and Specifications
13.4.3 Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Sanwa Kagaku Kenkyusho Main Business Overview
13.4.5 Sanwa Kagaku Kenkyusho Latest Developments
13.5 Towa Pharmaceutical
13.5.1 Towa Pharmaceutical Company Information
13.5.2 Towa Pharmaceutical Uric Acid-lowering Drugs Product Portfolios and Specifications
13.5.3 Towa Pharmaceutical Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Towa Pharmaceutical Main Business Overview
13.5.5 Towa Pharmaceutical Latest Developments
13.6 Toa Eiyo
13.6.1 Toa Eiyo Company Information
13.6.2 Toa Eiyo Uric Acid-lowering Drugs Product Portfolios and Specifications
13.6.3 Toa Eiyo Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Toa Eiyo Main Business Overview
13.6.5 Toa Eiyo Latest Developments
13.7 AstraZeneca
13.7.1 AstraZeneca Company Information
13.7.2 AstraZeneca Uric Acid-lowering Drugs Product Portfolios and Specifications
13.7.3 AstraZeneca Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 AstraZeneca Main Business Overview
13.7.5 AstraZeneca Latest Developments
13.8 Mochida Pharmaceutical
13.8.1 Mochida Pharmaceutical Company Information
13.8.2 Mochida Pharmaceutical Uric Acid-lowering Drugs Product Portfolios and Specifications
13.8.3 Mochida Pharmaceutical Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Mochida Pharmaceutical Main Business Overview
13.8.5 Mochida Pharmaceutical Latest Developments
13.9 Lannett Company
13.9.1 Lannett Company Company Information
13.9.2 Lannett Company Uric Acid-lowering Drugs Product Portfolios and Specifications
13.9.3 Lannett Company Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Lannett Company Main Business Overview
13.9.5 Lannett Company Latest Developments
13.10 Horizo??n Therapeutics
13.10.1 Horizo??n Therapeutics Company Information
13.10.2 Horizo??n Therapeutics Uric Acid-lowering Drugs Product Portfolios and Specifications
13.10.3 Horizo??n Therapeutics Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 Horizo??n Therapeutics Main Business Overview
13.10.5 Horizo??n Therapeutics Latest Developments
13.11 Sanofi
13.11.1 Sanofi Company Information
13.11.2 Sanofi Uric Acid-lowering Drugs Product Portfolios and Specifications
13.11.3 Sanofi Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 Sanofi Main Business Overview
13.11.5 Sanofi Latest Developments
13.12 GSK
13.12.1 GSK Company Information
13.12.2 GSK Uric Acid-lowering Drugs Product Portfolios and Specifications
13.12.3 GSK Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 GSK Main Business Overview
13.12.5 GSK Latest Developments
13.13 Fuji Yakuhin
13.13.1 Fuji Yakuhin Company Information
13.13.2 Fuji Yakuhin Uric Acid-lowering Drugs Product Portfolios and Specifications
13.13.3 Fuji Yakuhin Uric Acid-lowering Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Fuji Yakuhin Main Business Overview
13.13.5 Fuji Yakuhin Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Uric Acid-lowering Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Uric Acid-lowering Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Uric Acid Production Inhibitors
Table 4. Major Players of Urate-stimulating Excretion Agents
Table 5. Major Players of Uric Acid Dissolving Agents
Table 6. Global Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Uric Acid-lowering Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Uric Acid-lowering Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Uric Acid-lowering Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global Uric Acid-lowering Drugs Sale Market Share by Application (2021-2026)
Table 13. Global Uric Acid-lowering Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global Uric Acid-lowering Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global Uric Acid-lowering Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Uric Acid-lowering Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global Uric Acid-lowering Drugs Sales Market Share by Company (2021-2026)
Table 18. Global Uric Acid-lowering Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Uric Acid-lowering Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global Uric Acid-lowering Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Uric Acid-lowering Drugs Producing Area Distribution and Sales Area
Table 22. Players Uric Acid-lowering Drugs Products Offered
Table 23. Uric Acid-lowering Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Uric Acid-lowering Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Uric Acid-lowering Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global Uric Acid-lowering Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Uric Acid-lowering Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Uric Acid-lowering Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Uric Acid-lowering Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global Uric Acid-lowering Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Uric Acid-lowering Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Uric Acid-lowering Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas Uric Acid-lowering Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas Uric Acid-lowering Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas Uric Acid-lowering Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC Uric Acid-lowering Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC Uric Acid-lowering Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC Uric Acid-lowering Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC Uric Acid-lowering Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe Uric Acid-lowering Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe Uric Acid-lowering Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe Uric Acid-lowering Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Uric Acid-lowering Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Uric Acid-lowering Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Uric Acid-lowering Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Uric Acid-lowering Drugs
Table 53. Key Market Challenges & Risks of Uric Acid-lowering Drugs
Table 54. Key Industry Trends of Uric Acid-lowering Drugs
Table 55. Uric Acid-lowering Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Uric Acid-lowering Drugs Distributors List
Table 58. Uric Acid-lowering Drugs Customer List
Table 59. Global Uric Acid-lowering Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Uric Acid-lowering Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Uric Acid-lowering Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Uric Acid-lowering Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Uric Acid-lowering Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Uric Acid-lowering Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Uric Acid-lowering Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Uric Acid-lowering Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Uric Acid-lowering Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Uric Acid-lowering Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Uric Acid-lowering Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Uric Acid-lowering Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Uric Acid-lowering Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Uric Acid-lowering Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Teva Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Teva Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 75. Teva Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Teva Main Business
Table 77. Teva Latest Developments
Table 78. Mylan Pharmaceuticals Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Pharmaceuticals Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 80. Mylan Pharmaceuticals Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Mylan Pharmaceuticals Main Business
Table 82. Mylan Pharmaceuticals Latest Developments
Table 83. Takeda Pharmaceuticals Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Pharmaceuticals Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 85. Takeda Pharmaceuticals Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Takeda Pharmaceuticals Main Business
Table 87. Takeda Pharmaceuticals Latest Developments
Table 88. Sanwa Kagaku Kenkyusho Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 90. Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sanwa Kagaku Kenkyusho Main Business
Table 92. Sanwa Kagaku Kenkyusho Latest Developments
Table 93. Towa Pharmaceutical Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Towa Pharmaceutical Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 95. Towa Pharmaceutical Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Towa Pharmaceutical Main Business
Table 97. Towa Pharmaceutical Latest Developments
Table 98. Toa Eiyo Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Toa Eiyo Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 100. Toa Eiyo Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Toa Eiyo Main Business
Table 102. Toa Eiyo Latest Developments
Table 103. AstraZeneca Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 105. AstraZeneca Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. AstraZeneca Main Business
Table 107. AstraZeneca Latest Developments
Table 108. Mochida Pharmaceutical Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Mochida Pharmaceutical Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 110. Mochida Pharmaceutical Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Mochida Pharmaceutical Main Business
Table 112. Mochida Pharmaceutical Latest Developments
Table 113. Lannett Company Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Lannett Company Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 115. Lannett Company Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lannett Company Main Business
Table 117. Lannett Company Latest Developments
Table 118. Horizo??n Therapeutics Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Horizo??n Therapeutics Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 120. Horizo??n Therapeutics Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Horizo??n Therapeutics Main Business
Table 122. Horizo??n Therapeutics Latest Developments
Table 123. Sanofi Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 125. Sanofi Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 128. GSK Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. GSK Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 130. GSK Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. GSK Main Business
Table 132. GSK Latest Developments
Table 133. Fuji Yakuhin Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Fuji Yakuhin Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 135. Fuji Yakuhin Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Fuji Yakuhin Main Business
Table 137. Fuji Yakuhin Latest Developments
Table 1. Uric Acid-lowering Drugs Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Uric Acid-lowering Drugs Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Uric Acid Production Inhibitors
Table 4. Major Players of Urate-stimulating Excretion Agents
Table 5. Major Players of Uric Acid Dissolving Agents
Table 6. Global Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 7. Global Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Table 8. Global Uric Acid-lowering Drugs Revenue by Type (2021-2026) & ($ million)
Table 9. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2021-2026)
Table 10. Global Uric Acid-lowering Drugs Sale Price by Type (2021-2026) & (US$/Unit)
Table 11. Global Uric Acid-lowering Drugs Sale by Application (2021-2026) & (K Units)
Table 12. Global Uric Acid-lowering Drugs Sale Market Share by Application (2021-2026)
Table 13. Global Uric Acid-lowering Drugs Revenue by Application (2021-2026) & ($ million)
Table 14. Global Uric Acid-lowering Drugs Revenue Market Share by Application (2021-2026)
Table 15. Global Uric Acid-lowering Drugs Sale Price by Application (2021-2026) & (US$/Unit)
Table 16. Global Uric Acid-lowering Drugs Sales by Company (2021-2026) & (K Units)
Table 17. Global Uric Acid-lowering Drugs Sales Market Share by Company (2021-2026)
Table 18. Global Uric Acid-lowering Drugs Revenue by Company (2021-2026) & ($ millions)
Table 19. Global Uric Acid-lowering Drugs Revenue Market Share by Company (2021-2026)
Table 20. Global Uric Acid-lowering Drugs Sale Price by Company (2021-2026) & (US$/Unit)
Table 21. Key Manufacturers Uric Acid-lowering Drugs Producing Area Distribution and Sales Area
Table 22. Players Uric Acid-lowering Drugs Products Offered
Table 23. Uric Acid-lowering Drugs Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 24. New Products and Potential Entrants
Table 25. Market M&A Activity & Strategy
Table 26. Global Uric Acid-lowering Drugs Sales by Geographic Region (2021-2026) & (K Units)
Table 27. Global Uric Acid-lowering Drugs Sales Market Share Geographic Region (2021-2026)
Table 28. Global Uric Acid-lowering Drugs Revenue by Geographic Region (2021-2026) & ($ millions)
Table 29. Global Uric Acid-lowering Drugs Revenue Market Share by Geographic Region (2021-2026)
Table 30. Global Uric Acid-lowering Drugs Sales by Country/Region (2021-2026) & (K Units)
Table 31. Global Uric Acid-lowering Drugs Sales Market Share by Country/Region (2021-2026)
Table 32. Global Uric Acid-lowering Drugs Revenue by Country/Region (2021-2026) & ($ millions)
Table 33. Global Uric Acid-lowering Drugs Revenue Market Share by Country/Region (2021-2026)
Table 34. Americas Uric Acid-lowering Drugs Sales by Country (2021-2026) & (K Units)
Table 35. Americas Uric Acid-lowering Drugs Sales Market Share by Country (2021-2026)
Table 36. Americas Uric Acid-lowering Drugs Revenue by Country (2021-2026) & ($ millions)
Table 37. Americas Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 38. Americas Uric Acid-lowering Drugs Sales by Application (2021-2026) & (K Units)
Table 39. APAC Uric Acid-lowering Drugs Sales by Region (2021-2026) & (K Units)
Table 40. APAC Uric Acid-lowering Drugs Sales Market Share by Region (2021-2026)
Table 41. APAC Uric Acid-lowering Drugs Revenue by Region (2021-2026) & ($ millions)
Table 42. APAC Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 43. APAC Uric Acid-lowering Drugs Sales by Application (2021-2026) & (K Units)
Table 44. Europe Uric Acid-lowering Drugs Sales by Country (2021-2026) & (K Units)
Table 45. Europe Uric Acid-lowering Drugs Revenue by Country (2021-2026) & ($ millions)
Table 46. Europe Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 47. Europe Uric Acid-lowering Drugs Sales by Application (2021-2026) & (K Units)
Table 48. Middle East & Africa Uric Acid-lowering Drugs Sales by Country (2021-2026) & (K Units)
Table 49. Middle East & Africa Uric Acid-lowering Drugs Revenue Market Share by Country (2021-2026)
Table 50. Middle East & Africa Uric Acid-lowering Drugs Sales by Type (2021-2026) & (K Units)
Table 51. Middle East & Africa Uric Acid-lowering Drugs Sales by Application (2021-2026) & (K Units)
Table 52. Key Market Drivers & Growth Opportunities of Uric Acid-lowering Drugs
Table 53. Key Market Challenges & Risks of Uric Acid-lowering Drugs
Table 54. Key Industry Trends of Uric Acid-lowering Drugs
Table 55. Uric Acid-lowering Drugs Raw Material
Table 56. Key Suppliers of Raw Materials
Table 57. Uric Acid-lowering Drugs Distributors List
Table 58. Uric Acid-lowering Drugs Customer List
Table 59. Global Uric Acid-lowering Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 60. Global Uric Acid-lowering Drugs Revenue Forecast by Region (2027-2032) & ($ millions)
Table 61. Americas Uric Acid-lowering Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 62. Americas Uric Acid-lowering Drugs Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 63. APAC Uric Acid-lowering Drugs Sales Forecast by Region (2027-2032) & (K Units)
Table 64. APAC Uric Acid-lowering Drugs Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 65. Europe Uric Acid-lowering Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 66. Europe Uric Acid-lowering Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 67. Middle East & Africa Uric Acid-lowering Drugs Sales Forecast by Country (2027-2032) & (K Units)
Table 68. Middle East & Africa Uric Acid-lowering Drugs Revenue Forecast by Country (2027-2032) & ($ millions)
Table 69. Global Uric Acid-lowering Drugs Sales Forecast by Type (2027-2032) & (K Units)
Table 70. Global Uric Acid-lowering Drugs Revenue Forecast by Type (2027-2032) & ($ millions)
Table 71. Global Uric Acid-lowering Drugs Sales Forecast by Application (2027-2032) & (K Units)
Table 72. Global Uric Acid-lowering Drugs Revenue Forecast by Application (2027-2032) & ($ millions)
Table 73. Teva Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 74. Teva Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 75. Teva Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 76. Teva Main Business
Table 77. Teva Latest Developments
Table 78. Mylan Pharmaceuticals Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 79. Mylan Pharmaceuticals Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 80. Mylan Pharmaceuticals Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 81. Mylan Pharmaceuticals Main Business
Table 82. Mylan Pharmaceuticals Latest Developments
Table 83. Takeda Pharmaceuticals Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 84. Takeda Pharmaceuticals Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 85. Takeda Pharmaceuticals Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 86. Takeda Pharmaceuticals Main Business
Table 87. Takeda Pharmaceuticals Latest Developments
Table 88. Sanwa Kagaku Kenkyusho Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 89. Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 90. Sanwa Kagaku Kenkyusho Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 91. Sanwa Kagaku Kenkyusho Main Business
Table 92. Sanwa Kagaku Kenkyusho Latest Developments
Table 93. Towa Pharmaceutical Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 94. Towa Pharmaceutical Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 95. Towa Pharmaceutical Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 96. Towa Pharmaceutical Main Business
Table 97. Towa Pharmaceutical Latest Developments
Table 98. Toa Eiyo Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 99. Toa Eiyo Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 100. Toa Eiyo Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 101. Toa Eiyo Main Business
Table 102. Toa Eiyo Latest Developments
Table 103. AstraZeneca Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 104. AstraZeneca Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 105. AstraZeneca Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 106. AstraZeneca Main Business
Table 107. AstraZeneca Latest Developments
Table 108. Mochida Pharmaceutical Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 109. Mochida Pharmaceutical Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 110. Mochida Pharmaceutical Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 111. Mochida Pharmaceutical Main Business
Table 112. Mochida Pharmaceutical Latest Developments
Table 113. Lannett Company Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 114. Lannett Company Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 115. Lannett Company Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 116. Lannett Company Main Business
Table 117. Lannett Company Latest Developments
Table 118. Horizo??n Therapeutics Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 119. Horizo??n Therapeutics Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 120. Horizo??n Therapeutics Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 121. Horizo??n Therapeutics Main Business
Table 122. Horizo??n Therapeutics Latest Developments
Table 123. Sanofi Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 124. Sanofi Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 125. Sanofi Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 126. Sanofi Main Business
Table 127. Sanofi Latest Developments
Table 128. GSK Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 129. GSK Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 130. GSK Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 131. GSK Main Business
Table 132. GSK Latest Developments
Table 133. Fuji Yakuhin Basic Information, Uric Acid-lowering Drugs Manufacturing Base, Sales Area and Its Competitors
Table 134. Fuji Yakuhin Uric Acid-lowering Drugs Product Portfolios and Specifications
Table 135. Fuji Yakuhin Uric Acid-lowering Drugs Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 136. Fuji Yakuhin Main Business
Table 137. Fuji Yakuhin Latest Developments
LIST OF FIGURES
Figure 1. Picture of Uric Acid-lowering Drugs
Figure 2. Uric Acid-lowering Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Uric Acid-lowering Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Uric Acid-lowering Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Uric Acid-lowering Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Uric Acid-lowering Drugs Sales Market Share by Country/Region (2025)
Figure 10. Uric Acid-lowering Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Uric Acid Production Inhibitors
Figure 12. Product Picture of Urate-stimulating Excretion Agents
Figure 13. Product Picture of Uric Acid Dissolving Agents
Figure 14. Global Uric Acid-lowering Drugs Sales Market Share by Type in 2026
Figure 15. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Uric Acid-lowering Drugs Consumed in Hyperuricemia
Figure 17. Global Uric Acid-lowering Drugs Market: Hyperuricemia (2021-2026) & (K Units)
Figure 18. Uric Acid-lowering Drugs Consumed in Uric Acid Kidney Stones
Figure 19. Global Uric Acid-lowering Drugs Market: Uric Acid Kidney Stones (2021-2026) & (K Units)
Figure 20. Uric Acid-lowering Drugs Consumed in Gout
Figure 21. Global Uric Acid-lowering Drugs Market: Gout (2021-2026) & (K Units)
Figure 22. Uric Acid-lowering Drugs Consumed in Other
Figure 23. Global Uric Acid-lowering Drugs Market: Other (2021-2026) & (K Units)
Figure 24. Global Uric Acid-lowering Drugs Sale Market Share by Application (2025)
Figure 25. Global Uric Acid-lowering Drugs Revenue Market Share by Application in 2026
Figure 26. Uric Acid-lowering Drugs Sales by Company in 2026 (K Units)
Figure 27. Global Uric Acid-lowering Drugs Sales Market Share by Company in 2026
Figure 28. Uric Acid-lowering Drugs Revenue by Company in 2026 ($ millions)
Figure 29. Global Uric Acid-lowering Drugs Revenue Market Share by Company in 2026
Figure 30. Global Uric Acid-lowering Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Uric Acid-lowering Drugs Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Uric Acid-lowering Drugs Sales 2021-2026 (K Units)
Figure 33. Americas Uric Acid-lowering Drugs Revenue 2021-2026 ($ millions)
Figure 34. APAC Uric Acid-lowering Drugs Sales 2021-2026 (K Units)
Figure 35. APAC Uric Acid-lowering Drugs Revenue 2021-2026 ($ millions)
Figure 36. Europe Uric Acid-lowering Drugs Sales 2021-2026 (K Units)
Figure 37. Europe Uric Acid-lowering Drugs Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Uric Acid-lowering Drugs Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Uric Acid-lowering Drugs Revenue 2021-2026 ($ millions)
Figure 40. Americas Uric Acid-lowering Drugs Sales Market Share by Country in 2026
Figure 41. Americas Uric Acid-lowering Drugs Revenue Market Share by Country (2021-2026)
Figure 42. Americas Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Figure 43. Americas Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026)
Figure 44. United States Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Uric Acid-lowering Drugs Sales Market Share by Region in 2026
Figure 49. APAC Uric Acid-lowering Drugs Revenue Market Share by Region (2021-2026)
Figure 50. APAC Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Figure 51. APAC Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026)
Figure 52. China Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. India Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Uric Acid-lowering Drugs Sales Market Share by Country in 2026
Figure 60. Europe Uric Acid-lowering Drugs Revenue Market Share by Country (2021-2026)
Figure 61. Europe Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Figure 62. Europe Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026)
Figure 63. Germany Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. France Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Uric Acid-lowering Drugs Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026)
Figure 71. Egypt Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Uric Acid-lowering Drugs in 2026
Figure 77. Manufacturing Process Analysis of Uric Acid-lowering Drugs
Figure 78. Industry Chain Structure of Uric Acid-lowering Drugs
Figure 79. Channels of Distribution
Figure 80. Global Uric Acid-lowering Drugs Sales Market Forecast by Region (2027-2032)
Figure 81. Global Uric Acid-lowering Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Uric Acid-lowering Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Uric Acid-lowering Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Uric Acid-lowering Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Uric Acid-lowering Drugs Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Uric Acid-lowering Drugs
Figure 2. Uric Acid-lowering Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Uric Acid-lowering Drugs Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Uric Acid-lowering Drugs Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Uric Acid-lowering Drugs Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Uric Acid-lowering Drugs Sales Market Share by Country/Region (2025)
Figure 10. Uric Acid-lowering Drugs Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Uric Acid Production Inhibitors
Figure 12. Product Picture of Urate-stimulating Excretion Agents
Figure 13. Product Picture of Uric Acid Dissolving Agents
Figure 14. Global Uric Acid-lowering Drugs Sales Market Share by Type in 2026
Figure 15. Global Uric Acid-lowering Drugs Revenue Market Share by Type (2021-2026)
Figure 16. Uric Acid-lowering Drugs Consumed in Hyperuricemia
Figure 17. Global Uric Acid-lowering Drugs Market: Hyperuricemia (2021-2026) & (K Units)
Figure 18. Uric Acid-lowering Drugs Consumed in Uric Acid Kidney Stones
Figure 19. Global Uric Acid-lowering Drugs Market: Uric Acid Kidney Stones (2021-2026) & (K Units)
Figure 20. Uric Acid-lowering Drugs Consumed in Gout
Figure 21. Global Uric Acid-lowering Drugs Market: Gout (2021-2026) & (K Units)
Figure 22. Uric Acid-lowering Drugs Consumed in Other
Figure 23. Global Uric Acid-lowering Drugs Market: Other (2021-2026) & (K Units)
Figure 24. Global Uric Acid-lowering Drugs Sale Market Share by Application (2025)
Figure 25. Global Uric Acid-lowering Drugs Revenue Market Share by Application in 2026
Figure 26. Uric Acid-lowering Drugs Sales by Company in 2026 (K Units)
Figure 27. Global Uric Acid-lowering Drugs Sales Market Share by Company in 2026
Figure 28. Uric Acid-lowering Drugs Revenue by Company in 2026 ($ millions)
Figure 29. Global Uric Acid-lowering Drugs Revenue Market Share by Company in 2026
Figure 30. Global Uric Acid-lowering Drugs Sales Market Share by Geographic Region (2021-2026)
Figure 31. Global Uric Acid-lowering Drugs Revenue Market Share by Geographic Region in 2026
Figure 32. Americas Uric Acid-lowering Drugs Sales 2021-2026 (K Units)
Figure 33. Americas Uric Acid-lowering Drugs Revenue 2021-2026 ($ millions)
Figure 34. APAC Uric Acid-lowering Drugs Sales 2021-2026 (K Units)
Figure 35. APAC Uric Acid-lowering Drugs Revenue 2021-2026 ($ millions)
Figure 36. Europe Uric Acid-lowering Drugs Sales 2021-2026 (K Units)
Figure 37. Europe Uric Acid-lowering Drugs Revenue 2021-2026 ($ millions)
Figure 38. Middle East & Africa Uric Acid-lowering Drugs Sales 2021-2026 (K Units)
Figure 39. Middle East & Africa Uric Acid-lowering Drugs Revenue 2021-2026 ($ millions)
Figure 40. Americas Uric Acid-lowering Drugs Sales Market Share by Country in 2026
Figure 41. Americas Uric Acid-lowering Drugs Revenue Market Share by Country (2021-2026)
Figure 42. Americas Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Figure 43. Americas Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026)
Figure 44. United States Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 45. Canada Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 46. Mexico Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 47. Brazil Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 48. APAC Uric Acid-lowering Drugs Sales Market Share by Region in 2026
Figure 49. APAC Uric Acid-lowering Drugs Revenue Market Share by Region (2021-2026)
Figure 50. APAC Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Figure 51. APAC Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026)
Figure 52. China Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 53. Japan Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 54. South Korea Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 55. Southeast Asia Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 56. India Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 57. Australia Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 58. China Taiwan Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 59. Europe Uric Acid-lowering Drugs Sales Market Share by Country in 2026
Figure 60. Europe Uric Acid-lowering Drugs Revenue Market Share by Country (2021-2026)
Figure 61. Europe Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Figure 62. Europe Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026)
Figure 63. Germany Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 64. France Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 65. UK Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 66. Italy Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 67. Russia Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 68. Middle East & Africa Uric Acid-lowering Drugs Sales Market Share by Country (2021-2026)
Figure 69. Middle East & Africa Uric Acid-lowering Drugs Sales Market Share by Type (2021-2026)
Figure 70. Middle East & Africa Uric Acid-lowering Drugs Sales Market Share by Application (2021-2026)
Figure 71. Egypt Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 72. South Africa Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 73. Israel Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 74. Turkey Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 75. GCC Countries Uric Acid-lowering Drugs Revenue Growth 2021-2026 ($ millions)
Figure 76. Manufacturing Cost Structure Analysis of Uric Acid-lowering Drugs in 2026
Figure 77. Manufacturing Process Analysis of Uric Acid-lowering Drugs
Figure 78. Industry Chain Structure of Uric Acid-lowering Drugs
Figure 79. Channels of Distribution
Figure 80. Global Uric Acid-lowering Drugs Sales Market Forecast by Region (2027-2032)
Figure 81. Global Uric Acid-lowering Drugs Revenue Market Share Forecast by Region (2027-2032)
Figure 82. Global Uric Acid-lowering Drugs Sales Market Share Forecast by Type (2027-2032)
Figure 83. Global Uric Acid-lowering Drugs Revenue Market Share Forecast by Type (2027-2032)
Figure 84. Global Uric Acid-lowering Drugs Sales Market Share Forecast by Application (2027-2032)
Figure 85. Global Uric Acid-lowering Drugs Revenue Market Share Forecast by Application (2027-2032)
